Scientists report that they have learned how certain combinations of rearranged genes can promote the progression of a rare ...

The future is bright for prostate cancer research. It's glowing, in fact, thanks to new tools that combine the eye-catching ...

In a study published in Nature Communications, researchers at the University of Wisconsin–Madison introduced a deep learning ...

During a live event, Pedro C. Barata, MD, MSc, discussed the case of a patient with advanced clear cell renal cell carcinoma ...

Six years after Merck bought out Peloton Therapeutics, the New Jersey drugmaker is not remaining stationary with the crown ...